Big news out of Canada recently folks as that country’s answer to Berkshire Hathaway Inc., Fairfax Financial Holdings Ltd., sold almost 90% of its long-dated U.S. Treasury holdings in what appears to be a risk-off move on the cusp of U.S. elections and lingering global uncertainty.
Sorry for the title folks, but I couldn’t think of a catchier one. Continue reading
Investing genius Jeffrey Ubben and his team at ValueAct Capital Management L.P. were in the news on Monday with a report (form 13F) that fund or funds affiliated with the company had taken a roughly 2% stake in Wall Street giant and James Gorman-led financial services powerhouse Morgan Stanley.
What seemed to take many on the Street by surprise was that ValueAct was not seeking a seat on Morgan Stanley’s Board nor did it seek to criticize the actions of C.E.O Gorman. On the contrary, it would appear ValueAct thinks Gorman is running the firm quite well, and believes investors are not giving the company the credit it deserves.
In particular, ValueAct highlighted Morgan Stanley’s shift to asset-light and relatively lower risk businesses like wealth and investment management and investment banking advisory, which now account for about 80% of company profits.
Time will tell if this “passive” approach will pay off.
While I am nowhere in the same league as the geniuses at ValueAct Capital Management, I must admit that I did spend the majority of last Friday smiling upon reading the news that a fund associated with ValueAct Capital Management Continue reading